Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy

This publication has 22 references indexed in Scilit:

• Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method
  Annals of Surgical Oncology, 2000
• Thymidylate synthase (TS) protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil (5FU)
  European Journal Of Cancer, 1999
• Estimates of the worldwide mortality from 25 cancers in 1990
  International Journal of Cancer, 1999
• Immunohistochemical Quantitation of Thymidylate Synthase Expression in Colorectal Cancer Metastases Predicts for Clinical Outcome to Fluorouracil-Based Chemotherapy
  Journal of Clinical Oncology, 1999
• A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance
  Cancer, 1998
• Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.
  Journal of Clinical Oncology, 1997
• Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
  Journal of Clinical Oncology, 1996
• Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial
  European Journal Of Cancer, 1995
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• Thymidylate synthetase - a target enzyme in cancer chemotherapy
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1977